News
The FDA has approved a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted).
David King of Samsung Biologics shares insights on market demand and the technologies and capabilities needed to support ...
Vaccine Platform for Pandemic Preparedness and Global Immunization ATLANTA, GA - July 28, 2025 (NEWMEDIAWIRE) - GeoVax Labs, ...
Despite advancements, hepatitis remains a threat, fueled by unexpected sources like tattoos and unsafe medical practices. Dr.
ALPENA — Local health department officials say that mercury-based preservatives used in influenza immunizations do not affect long-term health, especially in children. U.S. Health and Human Services ...
In a proof-of-concept study, scientists have shown that flossing your teeth could be a way to deliver vaccinations that ...
HHS announced on Wednesday that it has adopted a recommendation from a CDC committee to remove thimerosal from all influenza vaccines.
The new shots won’t be available until the fall, and are expected to be approved only for adults 65 and up and kids and ...
5d
Dealbreaker on MSNSanofi Extends Respiratory Vaccines Reach With $1.15B Acquisition of Clinical-Stage VicebioThe deal complements an existing partnership with Novavax that encompasses R&D of combination vaccines for Covid-19 and flu.
HHS Secretary Robert F. Kennedy Jr. formally accepted recommendations that would require all vaccine manufacturers to ...
Sanofi acquires Vicebio for $1.15 billion, adding a next-gen RSV-hMPV vaccine and ‘Molecular Clamp' tech to strengthen its ...
The French pharma will pay $1.15 billion upfront to buy Vicebio and gain access to non-mRNA vaccine candidates against RSV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results